ACE2 and Hypertension: In this sense, it should be highlighted that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as a cell receptor for viral entry, whereas ACE is the target for certain therapeutic treatments for hypertension that could prevent vasoconstriction and disease conditions in Raynaud’s phenomenon.